In this review:
This Educational Series provides detailed insight into disease-background and disease-management issues in idiopathic pulmonary fibrosis (IPF), a devastating disorder for which no cure is currently available. However, exciting new treatments and possible combination schedules are emerging with the potential to slow disease progression and/or reduce mortality, thereby substantially shifting the management paradigm for IPF. Several such treatments are discussed in this review, which is intended for use by respiratory physicians and specialists. Expert commentary is provided by Professor Lutz Beckert.
Download PDF